SK285014B6 - Extrakt z Tanacetum parthenium, farmaceutický a perorálny kozmetický prostriedok s jeho obsahom - Google Patents

Extrakt z Tanacetum parthenium, farmaceutický a perorálny kozmetický prostriedok s jeho obsahom Download PDF

Info

Publication number
SK285014B6
SK285014B6 SK1748-2001A SK17482001A SK285014B6 SK 285014 B6 SK285014 B6 SK 285014B6 SK 17482001 A SK17482001 A SK 17482001A SK 285014 B6 SK285014 B6 SK 285014B6
Authority
SK
Slovakia
Prior art keywords
extract
polar solvent
extracts
extracting
tanacetum parthenium
Prior art date
Application number
SK1748-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK17482001A3 (sk
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11383110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK285014(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena S. P. A. filed Critical Indena S. P. A.
Publication of SK17482001A3 publication Critical patent/SK17482001A3/sk
Publication of SK285014B6 publication Critical patent/SK285014B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adornments (AREA)
  • Massaging Devices (AREA)
  • Cosmetics (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Air Bags (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1748-2001A 1999-06-03 2000-05-31 Extrakt z Tanacetum parthenium, farmaceutický a perorálny kozmetický prostriedok s jeho obsahom SK285014B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001244A IT1312342B1 (it) 1999-06-03 1999-06-03 Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
PCT/EP2000/004976 WO2000074695A2 (en) 1999-06-03 2000-05-31 Tanacetum parthenium extract

Publications (2)

Publication Number Publication Date
SK17482001A3 SK17482001A3 (sk) 2002-04-04
SK285014B6 true SK285014B6 (sk) 2006-04-06

Family

ID=11383110

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1748-2001A SK285014B6 (sk) 1999-06-03 2000-05-31 Extrakt z Tanacetum parthenium, farmaceutický a perorálny kozmetický prostriedok s jeho obsahom

Country Status (22)

Country Link
US (2) US6224875B1 (pt)
EP (1) EP1181030B1 (pt)
JP (1) JP4712258B2 (pt)
KR (1) KR100727121B1 (pt)
CN (1) CN1265814C (pt)
AT (1) ATE249232T1 (pt)
AU (1) AU769365B2 (pt)
CA (1) CA2375910C (pt)
CZ (1) CZ301703B6 (pt)
DE (1) DE60005174T2 (pt)
DK (1) DK1181030T3 (pt)
ES (1) ES2206251T3 (pt)
HK (1) HK1046245B (pt)
HU (1) HU228799B1 (pt)
IL (2) IL146841A0 (pt)
IT (1) IT1312342B1 (pt)
NO (1) NO328245B1 (pt)
PL (1) PL197514B1 (pt)
PT (1) PT1181030E (pt)
RU (1) RU2241475C2 (pt)
SK (1) SK285014B6 (pt)
WO (1) WO2000074695A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
DE60220145T2 (de) * 2001-03-16 2008-02-14 Johnson & Johnson Consumer Companies, Inc. Verwendung eines mutterkrautextrakts zur regulierung der hautalterung
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
CN1882354B (zh) * 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
AU2013201510B2 (en) * 2006-02-21 2015-07-16 Isp Investments Inc. Parthenolide Free Bioactive Ingredients from Feverfew (Tanacetum Parthenium) and Processes for their Production
BRPI0708095C1 (pt) * 2006-02-21 2021-05-25 Akzo Nobel Surface Chemistry Llc método para isolar uma fração bioativa, e, ingrediente bioativo
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US20110212042A1 (en) 2010-03-01 2011-09-01 Prithwiraj Maitra Skin care composition having desirable bulk color
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
FR2695931B1 (fr) 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
PT1100516E (pt) * 1999-06-03 2005-07-29 Johnson & Johnson Consumer Fr Extratos de matricaria (tanacetum parthenium) contra doencas inflamatorias

Also Published As

Publication number Publication date
DK1181030T3 (da) 2004-01-26
HK1046245B (zh) 2007-02-23
DE60005174D1 (de) 2003-10-16
US6479080B2 (en) 2002-11-12
NO20015867L (no) 2001-11-30
KR20020019452A (ko) 2002-03-12
AU5527200A (en) 2000-12-28
NO328245B1 (no) 2010-01-18
ITMI991244A0 (it) 1999-06-03
CZ301703B6 (cs) 2010-06-02
JP2003501392A (ja) 2003-01-14
ATE249232T1 (de) 2003-09-15
HUP0201258A3 (en) 2007-10-29
WO2000074695A3 (en) 2001-05-03
HU228799B1 (en) 2013-05-28
IT1312342B1 (it) 2002-04-15
JP4712258B2 (ja) 2011-06-29
IL146841A (en) 2006-12-31
NO20015867D0 (no) 2001-11-30
HK1046245A1 (en) 2003-01-03
RU2241475C2 (ru) 2004-12-10
US6224875B1 (en) 2001-05-01
ITMI991244A1 (it) 2000-12-03
CZ20014304A3 (cs) 2002-03-13
WO2000074695A2 (en) 2000-12-14
IL146841A0 (en) 2002-07-25
ES2206251T3 (es) 2004-05-16
KR100727121B1 (ko) 2007-06-12
SK17482001A3 (sk) 2002-04-04
US20010021400A1 (en) 2001-09-13
CN1353612A (zh) 2002-06-12
EP1181030B1 (en) 2003-09-10
PL197514B1 (pl) 2008-04-30
PT1181030E (pt) 2003-12-31
PL352107A1 (en) 2003-07-28
CN1265814C (zh) 2006-07-26
EP1181030A2 (en) 2002-02-27
DE60005174T2 (de) 2004-07-15
CA2375910C (en) 2011-11-01
CA2375910A1 (en) 2000-12-14
AU769365B2 (en) 2004-01-22
HUP0201258A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
EP1107775B2 (de) Pyrrolizidinalkaloidfreie petasites enthaltende zusammensetzung
SK285014B6 (sk) Extrakt z Tanacetum parthenium, farmaceutický a perorálny kozmetický prostriedok s jeho obsahom
Duwiejua et al. Anti-inflammatory activity of resins from some species of the plant family Burseraceae
US4925870A (en) Therapeutic use of proanthocyanidine A2 as a cytoprotective agent
KR100194830B1 (ko) 신규한 카페산의 유도체, 오라포시드, 및 그것을 함유하는 화장품 또는 약제학적 조성물, 특히 피부과학적 조성물
US20070003645A1 (en) Novel composition containing extracts of Butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity or pain
EP1848449A2 (en) Bioactive complex of triterpene acids, its production process and medicinal products with therapeutical uses
Patrick-Iwuanyanwu et al. Pelagia Research Library
EP1496920B1 (en) Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation
JP4071466B2 (ja) 新規なオルシノール誘導体
KR0137422B1 (ko) 아랄로사이드 a를 유효 성분으로 하는 위장 질환 치료제
DD293963A5 (de) Verfahren zur herstellung eines anthelminthikums
DE102022115137A1 (de) Zusammensetzung mit hepatoprotektiver Wirkung
Ahamed et al. Anti-inflammatory activity of Abutilon indicum.
WO2003084554A1 (de) Weidenextrakt
DE19732822C2 (de) Soja-Extrakt, dessen Herstellungsverfahren und diesen enthaltende pharmazeutische Zusammensetzungen und deren Verwendung für die Prävention oder Behandlung von Alkoholismus

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20170531